NIKAIA PHARMACEUTICALS:
FIGHTING CANCER AND AUTOIMMUNE DISEASES

​

By targeting the NIK protein, the molecule developed by Nikaia Pharmaceuticals helps fight certain cancers, by directing the patient’s immune defenses against the tumor while inhibiting its growth, and combats autoimmune diseases by regulating B-cell activity.

​

The illustration, divided into three parts, shows how the molecule acts on both types of disease, with the central panel depicting the destruction of the NIK protein. Each part can also be used independently to suit different formats.

​

Two versions for different purposes: the navy-blue version matches the company’s visual identity, while the lighter version is more suitable for internal presentations.

​

 

Project carried out in collaboration with Caroline Courme.

​

Technique: digital illustration.